Authors
Year
Country
Study period
Study type
KIT immunohistochemistry
Peak incidence (per 1,000,000)
Median age at diagnosis (years)
Goettsch et al. [15]
2005
Netherlands
1995–2003
Retrospective pathology review
Partial (87 %)
12.7
Not reported
Tryggvason et al. [14]
2005
Iceland
1990–2003
Retrospective pathology review
Yes
11a
65.8
Tran et al. [10]
2005
United States
1992–2000
SEER analysis
No
6.8a
63
Nilsson et al. [13]
2005
Western Sweden
1983–2000
Retrospective pathology review
Yes
14.5
69
Chan et al. [21]
2006
China
1995–2003
Retrospective pathology review
Yes
19.6a
66.6
Perez et al. [11]
2006
United States
1992–2002
SEER analysis
No
6.88a
63
Mucciarini et al. [17]
2007
Italy
1991–2004
Modena Cancer Registry analysis
Yes
6.6
69
Tzen et al. [19]
2007
Taiwan
1998–2004
Retrospective pathology review
Yes
13.74
Not reported
Ahmed et al. [16]
2008
United Kingdom
1987–2003
Retrospective pathology review
Yes
13.2
64.4
Monges et al. [18]
2010
France
2005
Prospective pathology review
Yes
10
65
Rubin et al. [12]
2011
United States
1993–2002
SEER analysis
No
3.2a
75
Chiang et al. [20]
2014
Taiwan
1998–2008
Taiwan Cancer Registry analysis
No
19.7a
62–64
Ma et al. [23]
2015
United States
2001–2011
SEER analysis
No
7.8a
64
4 Conclusion
In conclusion, many studies around the world have attempted to identify the incidence of GIST, ranging from national database analyses in the United States to retrospective pathological analyses conducted throughout Europe and Asia. The incidence of disease varies from 2.1 to 19.7 cases per million persons. GIST appears to be slightly more common in males than females with an average age range in the mid-60s and peak incidence in the 70s. For unclear reasons, race appears to be a factor in disease development with African Americans and Asian/Pacific Islanders being more commonly affected than Caucasians. As reported in every study, it is clear that the stomach is the most common tumor location followed by the small intestine. Finally, risk factors for death secondary to disease include increased age at diagnosis, male sex, Black race, and regional/metastatic disease. Despite increased understanding of the epidemiology of GIST over the last two decades, further studies are warranted to better define the incidence, prevalence, and risk factors for developing GIST.
References
1.
2.
3.
Herrera GA, Cerezo L, Jones JE, et al. Gastrointestinal autonomic nerve tumors. ‘Plexosarcomas’. Arch Pathol Lab Med. 1989;113(8):846–53.PubMed
4.
5.
Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23(4):377–89.CrossRefPubMed